Why a 50-Year-Old Should Skip a $50K 401(K) Loan
A 50-year-old considers borrowing from her 401(K) for home renovations. Analysts warn the real price is long-term gro...
Visa Cards That Earn Travel Points Without Fees
Earn travel points effortlessly with Visa cards that have no fees. Discover options that help you travel more for less!
23,594 articles
This Nuclear Tech Stock Delivers Growth Yet Faces Selloff
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
Alumis Stock Soared 400%: Cormorant Buys Another $8M
A sharp rise in Alumis shares coincides with a fresh stake from Cormorant Asset Management. This article breaks down ...
Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
High-Yield Healthcare Stocks Before Dividend Hikes: 2 Picks
In a market where dividends among healthcare firms can be elusive, two names stand out for investors seeking income n...
Bitcoin Outflows Exposing Wall Street's Crowded Trade
Bitcoin faces a tough test as ETF outflows converge with rising yields and a global risk-on mood. The phrase bitcoin ...
Bonds Used Answer Retirees: The 4.75% Covered-Call Shift
As market rates swing and volatility persists, a 4.75% yield from an active covered-call ETF is reshaping retirement ...
Frontier Capital Makes Stride: A Big Bet on Stride Stock
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
Cerebras Systems' Chips Faster: Two Nvidia Edges in AI Invest
Investors are eyeing Cerebras Systems' chips faster claims against Nvidia's Blackwell models. This deep dive explains...
What’s Going with KLAC: A Deep Dive Into KLAC Stock Trends
KLAC stock has captured investor attention as semiconductor tool demand shifts with AI and data growth. This guide br...
Why Poet Technologies Stock Plummeted This Week Explained
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status